Ju Kim retweeted
Meet the Houston Methodist Jeopardy team at #TCACC24!!
Best of luck for this Jeopardy Session🥁
@dr_chebrolu @NadeenFaza @txchapteracc @HMHCardioFellow @MethodistHosp @DeBakeyCVedu
🩺💙 The HMH Cardiology team is advancing heart care and making a real impact. #HMHCardiology #HeartHealth #Teamwork
I’m excited to invite you to the 9th Annual Houston Heart Failure Summit! Join us Saturday, 2/3/24 at @MethodistHosp or online. We are thrilled to have @DhariniRamu and @kamos16 as guest speakers reviewing the role of genetics in heart failure evaluation.
Thank you @mcolvin89 for joining us at @MethodistHosp and highlighting the importance of equity in access to advanced heart failure therapies! Look for the recording on the @DeBakeyCVedu YouTube channel to hear her insights into this critical issue.
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV assessment. Watch: youtube.com/watch?v=HTyZyoPW…
Join @DeBakeyCVedu tomorrow for the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD!
Register: learn.houstonmethodist.org/g…
5
809
Fantastic @HMethodistCV Grand Rounds by @RyanTedfordMD on RV reserve. Watch here: youtube.com/watch?v=HTyZyoPW….
Join @DeBakeyCVedu tomorrow at the George P. Noon Heart Failure Symposium to learn more from him and other leaders in the field of #LVAD.
Register learn.houstonmethodist.org/g…
Honored to present the @MethodistHosp experience in forming a #cardiogenicshock team on the international stage. Thank you @GTorreAmione @vicentejmzmd @ErasmoPA and @TecSaludMX. Congrats on a great 1st Annual Symposium for Cardiogenic Shock and Heart Failure!
Ju Kim retweeted
Thrilled to welcome Dr. Quarti’s exceptional experience in congenital surgery to support @HMethodistCV commitment to providing high quality care to our ACHD pts who need surgery, heart & multi organ transplant @HuieLin @CindyMMartinMD @WilliamZoghbi @AlanLumsdenMD @RayanYousefzai
Ju Kim retweeted
1/ Our RCT of med student guided tobacco cessation counseling of hospitalized patients in India
#MSCHAT trial is published in @JournalGIM
This implementation strategy
🌟⬆️ patient quit rates
🌟Improved student knowledge and confidence
Link ➡️rdcu.be/dd00B
🧵
Great discussion on the impact of tMCS has had on our field of HF by @AlpeshShahMD. Looking forward to PROTECT-IV at @HMethodistCV ! @SachinGoelMD @HuieLin @bobbi_hf @Abiomed
#HHFS2023 @AlpeshShahMD
Let's talk next about HOW we do PCI!
💥PROTECT-II: Impella-assisted better than IABP-assisted PCI.
But why?
📍Reduced complications
📍Enables optimal lesion selection
📍Renal protection
6
582
Join us THIS SATURDAY for an in depth review of the impact of co-morbid conditions on heart failure outcomes! Don’t miss the opportunity to interact with leaders in the field including @MarkDrazner and @robmentz! @HMinternalmed @HMHCardioFellow @HFSA
Need #CME and #CNE? Don't miss #HHFS2023 on Feb. 4! Hear the latest about #heartfailure, including updates on #cardiac and non-cardiac #comorbidities related to chronic heart failure. Register today https://xitter.cf/t.co/3rWIicGtKZ!
#CardioEd #MedEd @JuKimMD @CindyMMartinMD
Interested in learning more about #heartfailure #comorbidities? Join us on Feb. 4 for #HHFS2023. Get in-depth info on topics like #sleepdisordered breathing and heart failure with J. Georges Youssef, MD. REGISTER: https://xitter.cf/t.co/064X5kQe3W
@JuKimMD #HFSA
Incredibly blessed and proud to have @WilliamZoghbi as my chief and mentor. Truly an inspirational leader who sets the bar high & supports your efforts to surpass it. Congratulations on a well-deserved recognition! @HMHCardioFellow @MethodistHosp
Humbled & honored to be recognized by @ASE360 — an amazing organization spearheading education and innovation at its core, along with its 17k+ members!
8
1,424
We are excited to announce our second keynote for #HHFS2023: @robmentz. He will kick off the second session by discussing #cardiometabolic disease in #heartfailure! Join us on February 4, 2023! Learn more at https://xitter.cf/t.co/3rWIicGtKZ
@DukeHealth @JCardFail @CardioNerds #HFSA
We are excited to announce our first keynote speaker for #HHFS2023: @MarkDrazner! He will kick off the first session by discussing the evaluation of new-onset #heartfailure! Be sure to join on Feb. 4!
REGISTER NOW: https://xitter.cf/t.co/064X5kQe3W
#HFSA @utswheart @CindyMMartinMD
Join @DeBakeyCVedu on Saturday Feb 4 at the 8th Annual Houston Heart Failure Summit where @robmentz and @MarkDrazner will headline discussions on the latest in heart failure management such as this! @HFSA @HMHCardioFellow @HMethodistMD Register: learn.houstonmethodist.org/h…
GLP-1R agonists & SGLT2 inhibitors are recommended first-line therapies for type 2 diabetes in patients with increased CV risk. Glucocentric Drugs in CV Disease Protection & Heart Failure @drtalhakhawaja @gcfmd @virani_md @JavedButler1
#DeBakeyCVJournal
doi.org/10.14797/mdcvj.1155
Join us at the @TXMedCenter for #HHFS2023 on Feb. 4! Hear from experts, including @robmentz and @MarkDrazner, to get the latest #heartfailure updates. Both #CME and #CNE will be offered. Sign up today at https://xitter.cf/t.co/3rWIicGtKZ!
@JuKimMD #CardioEd #MedEd #HFSA
Calling all #Cardiology 1st year fellows: SAVE THE DATE: #CVBootCamp2022 Aug 5-7! Don't miss the opportunity to get hand-ons training in cardiac imaging, heart failure, and more!
APPLY NOW at https://xitter.cf/t.co/uE5sGD4hsh! Apps due July 1!
#CardioEd #CardioTwitter #EPeeps #WhyCMR
Ju Kim retweeted
#TBT to #ISHLT2022 where our @HMethodistCV heart failure family 🌟 came together, shared, learned, and had so much fun!
🧵Scroll & take a look!
Ju Kim retweeted
The 2022 #ISHLTEarlyCareer and Trainees Clinical Case Dilemmas Best Presentation Award goes to @HJRyooAli of @HMHCardioFellow! Her presentation was titled "Management of #PH Secondary to Valvular Heart Disease with Angiotensin-Receptor Neprilysin Inhibitor." Congrats! #ISHLT2022







































